PDPeter R. Durie

Peter R. Durie

*This is an algorithmically generated author record based on publicly available information.

Peter R. Durie has a total of 70 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Airway Mucosal Host Defense Is Key to Genomic Regulation of Cystic Fibrosis Lung Disease Severity

    by Deepika Polineni, Hong Dang, Paul J. Gallins, Lisa C. Jones, Rhonda G. Pace, Jaclyn R. Stonebraker, Leah A. Commander, Jeanne E. Krenicky, Yi-Hui Zhou, Harriet Corvol, et al.

    Rationale: The severity of cystic fibrosis (CF) lung disease varies widely, even for Phe508del homozygotes. Heritability studies show that more than 50% of the variability reflects non-cystic fibrosis transmembrane conductance regulator (CFTR) genetic variation; however, the full extent of the pertinent genetic variation is not known. Objectives: We sought to identify novel CF disease-modifying mechanisms using an integrated approach based on analyzing “in vivo” CF airway epithelial gene expression complemented with genome-wide association study (GWAS) data. Methods: Nasal mucosal RNA from 134 patients with CF was used for RNA sequencing. We tested for associations of transcriptomic (gene expression) data with a quantitative phenotype of CF lung disease severity. Pathway analysis of CF GWAS data (n = 5,659 patients) was performed to identify novel pathways and assess the concordance of genomic and transcriptomic data. Association of gene expression with previously identified CF GWAS risk alleles was also tested. Measurements and Main Results: Significant evidence of heritable gene expression was identified. Gene expression pathways relevant to airway mucosal host defense were significantly associated with CF lung disease severity, including viral infection, inflammation/inflammatory signaling, lipid metabolism, apoptosis, ion transport, Phe508del CFTR processing, and innate immune responses, including HLA (human leukocyte antigen) genes. Ion transport and CFTR processing pathways, as well as HLA genes, were identified across differential gene expression and GWAS signals. Conclusions: Transcriptomic analyses of CF airway epithelia, coupled to genomic (GWAS) analyses, highlight the role of heritable host defense variation in determining the pathophysiology of CF lung disease. The identification of these pathways provides opportunities to pursue targeted interventions to improve CF lung health.


  • Role of Sweat Testing in Patients With Idiopathic Pancreatitis

    by Chee Y. Ooi, Annie Dupuis, Katherine Keenan, Elizabeth Tullis, Peter R. Durie

  • Modulatory effect of the SLC9A3 gene on susceptibility to infections and pulmonary function in children with cystic fibrosis

    by Ruslan Dorfman, Chelsea Taylor, Fan Lin, Lei Sun, Andrew Sandford, Peter Paré, Yves Berthiaume, Mary Corey, Peter Durie, Julian Zielenski, et al.

    In cystic fibrosis (CF), CFTR dysfunction leads to salt and water imbalance across airway epithelia, depleted surface liquid layer, and impaired mucociliary clearance. This provides optimal conditions for chronic bacterial infections leading to excessive inflammation and progressive obstructive lung disease. We hypothesized that other epithelial channels affecting salt balance across the airways may play a role in the susceptibility to bacterial infections and modulate severity of CF lung disease. The SLC9A3 gene encoding a Na+/H+ exchanger was demonstrated to be a modifier intestinal disease in a murine model of CF. We examined the potential role of SLC9A3 as a modifier of CF lung disease severity. We analyzed 11 SLC9A3 gene variants for association with age of first Pseudomonas aeruginosa infection and lung function in children with CF. The T allele of an intronic variant in the SLC9A3 gene (rs4957061) was significantly (P = 0.02) associated with earlier acquisition of Pseudomonas infection in a cohort of 1,004 pediatric patients. Analysis of lung function in a subset of these patients (752) revealed that patients homozygous for the T allele had substantially reduced lung function and accelerated rate of decline. Although the functional basis for the modulatory effects of this SLC9A3 variant on CF lung disease remains to be elucidated, altered function of the Na+/H+ exchanger may further deplete the airway liquid surface, thereby enhancing susceptibility to Pseudomonas infections and worsening the severity of lung disease. Pediatr Pulmonol. 2011; 46:385–392.


  • Do common in silico tools predict the clinical consequences of amino‐acid substitutions in the CFTR gene?

    by R Dorfman, T Nalpathamkalam, C Taylor, T Gonska, K Keenan, Xw Yuan, M Corey, L‐C Tsui, J Zielenski, P Durie

    Dorfman R, Nalpathamkalam T, Taylor C, Gonska T, Keenan K, Yuan XW, Corey M, Tsui L‐C, Zielenski J, Durie P. Do common in silico tools predict the clinical consequences of amino‐acid substitutions in the CFTR gene?Computational methods are used to predict the molecular consequences of amino‐acid substitutions on the basis of evolutionary conservation or protein structure, but their utility in clinical diagnosis or prediction of disease outcome has not been well validated. We evaluated three popular computer programs, namely, PANTHER, SIFT and PolyPhen, by comparing the predicted clinical outcomes for a group of known CFTR missense mutations against the diagnosis of cystic fibrosis (CF) and clinical manifestations in cohorts of subjects with CF‐disease and CFTR‐related disorders carrying these mutations. Owing to poor specificity, none of tools reliably distinguished between individual mutations that confer CF disease from mutations found in subjects with a CFTR‐related disorder or no disease. Prediction scores for CFTR mutations derived from PANTHER showed a significant overall statistical correlation with the spectrum of disease severity associated with mutations in the CFTR gene. In contrast, PolyPhen‐ and SIFT‐derived scores only showed significant differences between CF‐causing and non‐CF variants. Current computational methods are not recommended for establishing or excluding a CF diagnosis, notably as a newborn screening strategy or in patients with equivocal test results.


  • Patterns of GI disease in adulthood associated with mutations in the CFTR gene

    by Michael Wilschanski, Peter R Durie

    We will first examine the clinical manifestations of CF disease that are directly associated with loss of function of the cystic fibrosis transmembrane regulator (CFTR) protein and then summarise those which are secondary. We will elaborate the challenges of establishing or excluding a CF diagnosis in patients who present de novo in adulthood, with particular attention to conditions with CF-like phenotypes that are associated with an increased frequency of mutations in the CFTR gene. Finally, we will briefly discuss emerging knowledge of the potential contribution of mutations in the CFTR gene to other complex genetic conditions.


  • Reply

    by Daina Kalnins, Mary Corey, Lynda Ellis, Paul Pencharz, Elizabeth Tullis, Peter R. Durie

  • Mutations in the Cystic Fibrosis Transmembrane Regulator Gene and In Vivo Transepithelial Potentials

    by Michael Wilschanski, Annie Dupuis, Lynda Ellis, Keith Jarvi, Julian Zielenski, Elizabeth Tullis, Sheelagh Martin, Mary Corey, Lap-Chee Tsui, Peter Durie

    Aim: To examine the relationship between cystic fibrosis transmembrane regulator gene mutations (CFTR) and in vivo transepithelial potentials. Methods: We prospectively evaluated 162 men including 31 healthy subjects, 21 obligate heterozygotes, 60 with congenital bilateral absence of the vas deferens (CBAVD) and 50 with CF by extensive CFTR genotyping, sweat chloride and nasal potential difference testing. Results: Six (10%) men with CBAVD carried no CFTR mutations, 18 (30%) carried one mutation, including the 5T variant, and 36 (60%) carried mutations on both alleles, for a significantly higher rate carrying one or more mutations than healthy controls (90% versus 19%, p < 0.001). There was an overlapping spectrum of ion channel measurements among the men with CBAVD, ranging from values in the control and obligate heterozygote range at one extreme, to values in the CF range at the other. All pancreatic-sufficient patients with CF and 34 of 36 patients with CBAVD with mutations on both alleles carried at least one mild mutation. However, the distribution of mild mutations in the two groups differed greatly. Genotyping, sweat chloride and nasal potential difference (alone or in combination) excluded CF in all CBAVD men with no mutations. CF was confirmed in 56% and 67% of CBAVD men carrying 1 and 2 CFTR mutations, respectively. Conclusion: Abnormalities of CFTR transepithelial function correlate with the number and severity of CFTR gene mutations.


  • Open Access

    The era of position statements and consensus documents: A source of clarity or confusion?

    by Peter R Durie, Anthony R Otley

    This issue of Paediatrics & Child Health includes a series of carefully selected articles on common gastrointestinal and nutritional disorders of childhood. The primary goal of this series is to provide the busy primary care practitioner and consultant paediatrician with up-to-date knowledge and a practical resource on how to evaluate and manage children with these common clinical problems. Most articles also offer advice concerning the indications for referring a patient to a subspecialist for additional consultative advice or evaluation.

  • Reply to coates and bush

    by Peter R. Durie, Paul Pencharz, Johanna M. Rommens, Julian Zielenski, Mary Corey, Elizabeth Tullis, Gregory Downey

  • Open Access

    Cystic fibrosis presenting as kwashiorkor in a Sri Lankan infant

    by M Mei-Zahav, M Solomon, A Kawamura, A Coates, P Durie

    Growth failure is a common presentation of patients with pancreatic insufficient cystic fibrosis. However, full blown kwashiorkor is extremely rare. Cystic fibrosis is also considered to be rare in the South Asian population. This report describes a Sri Lankan infant with cystic fibrosis who presented with clinical features of severe kwashiorkor.